Brief: Molecular Templates Announces FDA Acceptance Of IND Application For MT-6402
Jan 19 (Reuters) - Molecular Templates Inc MTEM.O :
* MOLECULAR TEMPLATES ANNOUNCES FDA ACCEPTANCE OF IND
APPLICATION
FOR MT-6402, A PD-L1-TARGETED ENGINEERED TOXIN BODY ENABLED WITH
PROPRIETARY ANTIGEN SEEDING TECHNOLOGY
* MOLECULAR TEMPLATES - EXPECTS TO START DOSING ENROLLED
SUBJECTS
IN PHASE 1 STUDY IN RELAPSED/REFRACTORY PATIENTS WITH
PD-L1-POSITIVE SOLID TUMORS IN Q2
Source text for Eikon: ID:nGNX3CJ6Fv
Further company coverage: MTEM.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Molecular Templates
See all newsBrief: Molecular Templates Co & Affiliate Commenced Chapter 11 Cases As DIP
Brief: Molecular Templates's Eric E. Poma Resigns As CEO, CSO, Treasurer, And Interim CFO
Brief: Molecular Templates Announces Notice Of Delisting And Failure To Satisfy Continued Listing Rules
Brief: Molecular Templates Announces Receipt Of Expected Notification Of Deficiency From Nasdaq
Brief: Molecular Templates Approved Liquidation & Wind Up Through A Dissolution